You are here: Industry Insights > Acquisition

News List

Takeda unlikely to sell OTC unit to pay Shire merger debts pharmaphorum
January 08, 2019
Takeda’s $59 billion takeover of Shire is due to close tomorrow (Tuesday) and the company’s CEO Christophe Weber has already given some strong clues about the company’s strategy once the deal completes.
Eli Lilly grabs spotlight at J.P. Morgan with $8B Loxo Oncology buyout fiercepharma
January 08, 2019
On the first day of biopharma’s largest confab, the J.P. Morgan Healthcare Conference, Eli Lilly confirmed that big-ticket M&A is back in fashion in the industry.
Post-Monsanto Era of Bayer Group: To Lay off 10,000+ Employees, Scale Back Business, and Develop Life Science PharmaSources/Youyi
January 08, 2019
Bayer formally acquired the U.S. agricultural company: Monsanto for a price of USD63 billion on June 7, 2018 upon approval of the relevant U.S. and European regulators.
Lilly Announces Agreement to Acquire Loxo Oncology americanpharmaceuticalreview
January 08, 2019
Eli Lilly and Company and Loxo Oncology announced a definitive agreement for Lilly to acquire Loxo Oncology for $235.00 per share in cash, or approximately $8.0 billion ......
BMS acquires Celgene for an equity value of $74bn pharmaceutical-technology
January 04, 2019
Bristol-Myers Squibb (BMS) has entered into a definitive merger agreement to acquire Celgene via a cash and stock transaction with an equity value of $74bn; Celgene shares have been valued at $102.43 per share.
BMS acquires Celgene for an equity value of $74bn pharmaceutical-technology
January 04, 2019
Bristol-Myers Squibb (BMS) has entered into a definitive merger agreement to acquire Celgene via a cash and stock transaction with an equity value of $74bn; Celgene shares have been valued at $102.43 per share....
ResMed to acquire connected inhaler developer Propeller Health for $225M fiercebiotech
January 03, 2019
Former Fierce 15 winner Propeller Health is being acquired by ResMed in a $225 million deal that aims to broaden the reach of its connected respiratory devices to patients across all stages of chronic obstructive pulmonary disease (COPD).....
Aralez completes sale of drug rights to Nuvo Pharmaceuticals for $110m pharmaceutical-technology
January 03, 2019
Canada-based Aralez Pharmaceuticals has completed the divestment of more than 20 medicines under its portfolio to Nuvo Pharmaceuticals for a total consideration of $110m......
Novartis offers to acquire CellforCure cphi-online
January 02, 2019
Proposed acquisition will expand manufacturing capacity for innovative cell and gene therapies.
Boston scientific exercises option to acquire Millipede, Inc. biospectrumasia
January 02, 2019
Boston Scientific Corporation has announced that it exercised its option to acquire the remaining shares of Millipede, Inc, a privately-held company in Santa Rosa, Calif., upon its recent successful completion of a first-in-human clinical study.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page